For R&D use only.

PFI-2 hydrochloride

  • Catalog NO.:A900859
  • CAS No. : 1627607-87-7
  • Molecular Formula:C23H26ClF4N3O3S
  • Molecular Weight: 535.98
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
HPLC/GC NMR

Product Details

CAS Number 1627607-87-7 Appearance
Catalog Number A900859 MDL Number
Molecular Formula C23H26ClF4N3O3S Molecular Weight 535.98
Boiling Point Melting Point
Flash Point Density
Synonyms (R)-8-fluoro-N-(1-oxo-1-(pyrrolidin-1-yl)-3-(3-(trifluoromethyl)phenyl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide hydrochloride
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors. Ponatinib was approved in 2012.

943319-70-8 (free base)

1114544-31-8 (HCl)

1232836-25-7 (tris-hydrochloride)

Related Products

Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

PFI-2 hydrochloride
(R)-8-fluoro-N-(1-oxo-1-(pyrrolidin-1-yl)-3-(3-(trifluoromethyl)phenyl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide hydrochloride